The in vitro effect of levamisole on lymphocyte proliferation, polymorphonuclear leucocyte chemotaxis, basophil histamine release and platelet serotonin release in patients with atopic dermatitis
- 1 November 1980
- journal article
- research article
- Published by Wiley in Clinical and Experimental Allergy
- Vol. 10 (6) , 705-713
- https://doi.org/10.1111/j.1365-2222.1980.tb02155.x
Abstract
The in vitro effect of levamisole (LMS) on lymphocyte, neutrophil, basophil and platelet function was investigated in patients with severe atopic dermatitis and hyper‐immunoglobulinaemia E. Lymphocyte stimulation by several concentrations of PHA, con A and PWM, polymorphonuclear leukocyte chemotaxis and basophil histamine release were unaffected by LMS (10 μg/ml). Platelet serotonin release induced by iodipamide was decreased in patient and control groups by LMS but release induced by methacholine, epinephrine and thrombin was not.This publication has 21 references indexed in Scilit:
- In vitro Histamine and Serotonin Release Studies in Atopic DermatitisInternational Archives of Allergy and Immunology, 1979
- Decreased Beta-Adrenergic Receptors on Polymorphonuclear Leukocytes after Adrenergic TherapyNew England Journal of Medicine, 1978
- Levamisole therapy in atopic dermatitis: randomized double-blind evaluationArchives of Dermatology, 1978
- The use of levamisole in atopic dermatitis: a prospective studyArchives of Dermatology, 1978
- Levamisole and human lymphocyte culturesPublished by Elsevier ,1977
- LEVAMISOLE IN WISKOTT-ALDRICH SYNDROMEThe Lancet, 1976
- Defective T cell function in atopic dermatitisJournal of Allergy and Clinical Immunology, 1976
- TRANSFER FACTOR IN ATOPIC DISEASEThe Lancet, 1976
- Effects of levamisole and imidazole on lymphocyte proliferation and cyclic nucleotide levelsCellular Immunology, 1975
- TRANSFER FACTOR IN SEVERE ATOPIC DISEASEThe Lancet, 1975